Featured Research

from universities, journals, and other organizations

Clinical trial reveals pterostilbene reduces blood pressure in adults

Date:
September 20, 2012
Source:
University of Mississippi
Summary:
A form of pterostilbene, a compound found naturally in blueberries, reduces blood pressure in adults, according to new results.

Blueberries.
Credit: ฉ Alexstar / Fotolia

A form of pterostilbene, a compound found naturally in blueberries, reduces blood pressure in adults, according to results of a clinical trial presented Sept. 20 at the American Heart Association's 2012 Scientific Sessions on High Blood Pressure Research in Washington, D.C.

Related Articles


The randomized, double-blind, placebo-controlled study was conducted by University of Mississippi School of Pharmacy and School of Medicine researchers to determine whether pterostilbene (tero-STILL-bean), an ingredient being marketed as pTeroPureฎ, improves cardiovascular health.

Investigators evaluated the ingredient in 80 patients with high cholesterol (total cholesterol of 200 or greater and/or LDL cholesterol of 100 or greater). Twice daily for six to eight weeks, participants received either high (125 mg) doses of pterostilbene, low (50 mg) doses of pterostilbene, pterostilbene (50 mg) with grape extract (100 mg), or a placebo, said Daniel M. Riche, the study's principal investigator. Investigators assessed patients' blood pressure, body weight and blood lipids at the beginning and end of their participation in the study.

"We found reduced systolic and diastolic blood pressure in patients who received the high dose of pterostilbene and reduced systolic blood pressure in patients who received the low dose of pterostilbene with grape extract," said Riche, an assistant professor of pharmacy practice and medicine at the UM Medical Center in Jackson.

Participants in the high-dose pterostilbene group (250 mg per day) achieved significant reductions in blood pressure compared to placebo: 7.8 mmHg in systolic BP (p less than 0.01) and 7.3 mmHg in diastolic BP (p less than 0.001).

The only change in lipids was an increase in LDL cholesterol with pterostilbene (24.9 mg/dL, p less than 0.001), which was less among participants already on cholesterol-lowering medication and was not seen among those who also received the grape extract. Participants not on cholesterol medication also achieved a minor average reduction in body weight (reduced body mass index of 0.59 kg/m2) with pterostilbene; body weight did not change significantly compared to placebo for the other participants.

Patent rights covering the use of pterostilbene for various health benefits were licensed from UM for commercial development two years ago by the ChromaDex Corp., which is marketing it as pTeroPure, the key ingredient in BluScience™, a line of dietary supplements available in some 17,000 outlets across the country. The California-based company provided support to the university for its yearlong clinical study (http://clinicaltrials.gov identifier NCT 01267227).

"We are pleased that the University of Mississippi Medical Center conducted our first human study, which was a key to us and our commitment to providing clinical proof for our ingredients," said Frank Jaksch Jr., CEO and co-founder of ChromaDex. "This is an important milestone for us in adding credibility to our products for further market expansion opportunities."

Along with Dr. Marion Wofford, professor of medicine, the study's co-investigators include Justin J. Sherman, associate professor of pharmacy practice; Michael E. Griswold, director of UMMC's Center for Biostatistics; and Krista D. Riche, clinical pharmacy specialist at St. Dominic Hospital in Jackson.

"We are pleased to work with ChromaDex to explore the potential of this dietary supplement ingredient to improve the health and well-being of people in the U.S. and around the globe," said School of Pharmacy Dean David D. Allen.

ChromaDex is a leader in the development of phytochemical and botanical reference standards and the creation of associated intellectual property. The company is committed to sustainable "green chemistry" and provides dietary supplement, food, beverage, nutraceutical and cosmetic industries with novel ingredients, analytical tools and services to meet product regulatory, quality, efficacy and safety standards.


Story Source:

The above story is based on materials provided by University of Mississippi. Note: Materials may be edited for content and length.


Cite This Page:

University of Mississippi. "Clinical trial reveals pterostilbene reduces blood pressure in adults." ScienceDaily. ScienceDaily, 20 September 2012. <www.sciencedaily.com/releases/2012/09/120920141008.htm>.
University of Mississippi. (2012, September 20). Clinical trial reveals pterostilbene reduces blood pressure in adults. ScienceDaily. Retrieved October 23, 2014 from www.sciencedaily.com/releases/2012/09/120920141008.htm
University of Mississippi. "Clinical trial reveals pterostilbene reduces blood pressure in adults." ScienceDaily. www.sciencedaily.com/releases/2012/09/120920141008.htm (accessed October 23, 2014).

Share This



More Health & Medicine News

Thursday, October 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Fears Keep Guinea Hospitals Empty

Ebola Fears Keep Guinea Hospitals Empty

AP (Oct. 23, 2014) — Fears of Ebola are keeping doctors and patients alike away from hospitals in the West African nation of Guinea. (Oct. 23) Video provided by AP
Powered by NewsLook.com
Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Working Mother (Oct. 22, 2014) — Is your child ready? Video provided by Working Mother
Powered by NewsLook.com
U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

Newsy (Oct. 22, 2014) — Now that the U.S. is restricting travel from West Africa, some are dropping questions about a travel ban and instead asking about visa bans. Video provided by Newsy
Powered by NewsLook.com
More People Diagnosed With TB In 2013, But There's Good News

More People Diagnosed With TB In 2013, But There's Good News

Newsy (Oct. 22, 2014) — The World Health Organizations says TB numbers rose in 2013, but it's partly due to better detection and more survivors. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins